International Trade Bulletin - Volume 1, Issue 1
Client Alert | 2 min read | 03.20.06
Inside this issue:
- CHINA IN THE SPOTLIGHT
- EUROPE IN THE SPOTLIGHT
- DUTY RECOVERY : Many importers and manufacturers pay unnecessary duty on imported merchandise, either directly or as a cost of procured materials
- BILATERAL TRADE: The proposed U.S. – Korea FTA will be the most commercially significant FTA the U.S. has negotiated since NAFTA
- FOREIGN INVESTMENTS: New Indian investment rules allow foreign retailers to set up majority-owned stores in India – a high-growth market eyed by foreign retailers for years
- AIR TRANSPORT: Controversial U.S. DOT proposal to attract investment in the U.S. Airlines draws fire from both sides of the pond rather than hope for Open Skies
- SANCTIONS: The Office of Foreign Assets Control (“OFAC”) of the U.S. Department of the Treasury has issued an interim final rule outlining a new set of enforcement procedures
- NAFTA: NAFTA provisions on “regional value content” (RVC) calculation causes serious problems for related parties
- DUTY SUSPENSION: The Miscellaneous Tariff Bill (MTB) may be more relevant to your business than it sounds - at least if you are an importer of products that American factories do not produce domestically
- INTERNATIONAL IP PROTECTION: Elements of India’s new patent law which took effect in 2005 have prevented Novartis from obtaining a patent for its cancer drug “Gleevec”
Contacts
Insights
Client Alert | 2 min read | 11.14.25
Claim construction is a key stage of most patent litigations, where the court must decide the meaning of any disputed terms in the patent claims. Generally, claim terms are given their plain and ordinary meaning except under two circumstances: (1) when the patentee acts as its own lexicographer and sets out a definition for the term; and (2) when the patentee disavows the full scope of the term either in the specification or during prosecution. Thorner v. Sony Comput. Ent. Am. LLC, 669 F.3d 1362, 1365 (Fed. Cir. 2012). The Federal Circuit’s recent decision in Aortic Innovations LLC v. Edwards Lifesciences Corp. highlights that patentees can act as their own lexicographers through consistent, interchangeable usage of terms across the specification, effectively defining terms by implication.
Client Alert | 6 min read | 11.14.25
Microplastics Update: Regulatory and Litigation Developments in 2025
Client Alert | 6 min read | 11.13.25
